SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Return
29.51%
This Quarter Return
+3.39%
1 Year Return
+29.51%
3 Year Return
+13.62%
5 Year Return
+117.76%
10 Year Return
+239.6%
AUM
$1.22B
AUM Growth
+$236M
(+24%)
Cap. Flow
+$226M
Cap. Flow
% of AUM
18.61%
Top 10 Holdings %
Top 10 Hldgs %
10.08%
Holding
636
New
201
Increased
78
Reduced
62
Closed
295
Top Buys
| 1 |
Goldman Sachs
GS
|
+$12.3M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$12.3M |
| 3 |
AbbVie
ABBV
|
+$12.2M |
| 4 |
Ulta Beauty
ULTA
|
+$12M |
| 5 |
Constellation Brands
STZ
|
+$11.7M |
Top Sells
| 1 |
Nutanix
NTNX
|
+$13.1M |
| 2 |
Southwest Airlines
LUV
|
+$10.2M |
| 3 |
Exxon Mobil
XOM
|
+$10.2M |
| 4 |
Costco
COST
|
+$9.96M |
| 5 |
PPL Corp
PPL
|
+$9.81M |
Sector Composition
| 1 | Consumer Discretionary | 21.31% |
| 2 | Technology | 17.79% |
| 3 | Financials | 12.54% |
| 4 | Healthcare | 11.75% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Ryanair
RYAAY
$31.2B
| – | – |
-14,250
| Closed | -$594K |
|
377
Sabre
SABR
$679M
| – | – |
-12,526
| Closed | -$257K |
|
|
SAGE
378
DELISTED
Sage Therapeutics
SAGE
| – | – |
-2,180
| Closed | -$359K |
|
379
Melco Resorts & Entertainment
MLCO
$3.8B
| – | – |
-10,059
| Closed | -$292K |
|
380
3M
MMM
$81.8B
| – | – |
-36,989
| Closed | -$7.28M |
|
381
Marathon Petroleum
MPC
$55.2B
| – | – |
-89,116
| Closed | -$5.88M |
|
382
Microsoft
MSFT
$3.72T
| – | – |
-27,735
| Closed | -$2.37M |
|
383
Madison Square Garden
MSGS
$4.93B
| – | – |
-2,243
| Closed | -$337K |
|
384
Motorola Solutions
MSI
$80.3B
| – | – |
-5,200
| Closed | -$470K |
|
385
Match Group
MTCH
$9.12B
| – | – |
-61,100
| Closed | -$1.91M |
|
386
MGIC Investment
MTG
$6.54B
| – | – |
-127,600
| Closed | -$1.8M |
|
387
Meritage Homes
MTH
$5.59B
| – | – |
-14,400
| Closed | -$369K |
|
388
Vail Resorts
MTN
$5.37B
| – | – |
-22,200
| Closed | -$4.72M |
|
389
Neurocrine Biosciences
NBIX
$14B
| – | – |
-31,500
| Closed | -$2.44M |
|
390
Norwegian Cruise Line
NCLH
$11.5B
| – | – |
-36,675
| Closed | -$1.95M |
|
391
Nordson
NDSN
$12.6B
| – | – |
-20,300
| Closed | -$2.97M |
|
392
Newmont
NEM
$86.2B
| – | – |
-232,370
| Closed | -$8.72M |
|
393
Ingevity
NGVT
$2.08B
| – | – |
-4,900
| Closed | -$345K |
|
394
NiSource
NI
$19.2B
| – | – |
-16,082
| Closed | -$413K |
|
395
Nektar Therapeutics
NKTR
$916M
| – | – |
-2,133
| Closed | -$1.91M |
|
396
NetApp
NTAP
$24.7B
| – | – |
-142,134
| Closed | -$7.86M |
|
397
Northern Trust
NTRS
$24.2B
| – | – |
-38,988
| Closed | -$3.9M |
|
398
NovoCure
NVCR
$1.37B
| – | – |
-33,600
| Closed | -$679K |
|
399
NVIDIA
NVDA
$4.32T
| – | – |
-564,960
| Closed | -$2.73M |
|
400
Newell Brands
NWL
$2.54B
| – | – |
-48,927
| Closed | -$1.51M |
|